09.12.2020 • NewsUmicoreCatalysis & Catalysts

Umicore Acquires YPhos Ligand Technology from Bochum University

Umicore‘s business unit Precious Metals Chemistry is further expanding its cross-coupling catalyst portfolio by acquiring Ruhr University Bochum’s YPhos ligands and catalysts technology.

Umicore‘s business unit Precious Metals Chemistry is further expanding its cross-coupling catalyst portfolio by acquiring Ruhr University Bochum’s YPhos ligands and catalysts technology. Recognized as one of the most elegant and versatile synthetic methods to prepare high-value chemicals, cross-coupling reactions have become essential in the synthesis of agrochemicals, electronic chemicals, fine chemicals or pharmaceuticals.

Invented by professor Viktoria Gessner’s research group, YPhos ligands are a novel class of phosphines bearing ylide substituents. They feature electronic and steric properties that show an excellent aptitude to support active transition metal catalysts, particularly in reactions where strong electron-donating ligands and steric protection of low coordinated species are required.

Compared to the currently best-known phosphine catalyst systems, YPhos ligands, combined with specific palladium-catalysts, showed a superior performance at room temperature Buchwald-Hartwig amination of aryl chlorides. They have additionally proven highly efficient in a wide range of challenging palladium-catalyzed α-arylation of alkyl ketones with aryl chlorides under mild conditions. Additionally, they feature outstanding performance in gold-catalyzed hydroamination and hydration reactions, using low catalyst loadings under mild reaction conditions.

Umicore now offers its customers worldwide a selection of YPhos ligand and catalyst systems on research and commercial scale. Research quantities are available from Umicore’s distribution partner Merck. This agreement with Ruhr-Bochum University enables Umicore to provide full access to an outstanding proprietary technology and to support its customers with an expanded portfolio of cutting-edge homogeneous catalysts and service offering, including Buchwald and Hazari precatalysts, Grubbs metathesis catalysts and many more.

Umicore Acquires YPhos Ligand Technology from Bochum University

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.